U.S. Diabetes Therapies and Complications Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

This report analyzes the U.S. diabetes therapies and complications markets, for the forecast period 1998 to 2008. The report is segmented into 5 chapters viz. Executive Summary, Total Market, Insulin Therapies Market, Oral Medications Market and Diabetes Complications Products Market. Each segment provides revenue forecasts, market share, pricing trends, demand analysis, competitive structure and market and technology trends. Drivers, restraints and challenges and the strategic recommendations are also discussed. The Market Engineering Awards are conferred on deserving companies.

Table of Contents

U.S. Diabetes Therapies and Complications Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Diabetes Therapies and Complications Markets, Total MarketOverviewIntroductionMarket Engineering AnalysisForecasts and TrendsDemand Analysis - IDemand Analysis - IIRevenue ForecastsMarket Share AnalysisChallengesChallenges OverviewIntroduction of Low-Cost Generics to Constrain Revenue GrowthHigh Cost of Medications Dissuades Potential UsersLarge Untreated Diabetic Population Obstructs Market Expansion EffortsAbsence of Diabetes Complications Therapies Blunts Growth OpportunityLow Awareness Restrains Appropriate UseAvailable Insulin Delivery Technologies Curb Insulin UseFrost & Sullivan Market Engineering AwardsMarket Engineering Leadership AwardMarketing Strategy AwardBusiness Development Strategy AwardMarket Penetration Strategy AwardProduct Innovation AwardU.S. Diabetes Therapies and Complications Markets, Insulin MarketOverviewIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsInhaled InsulinOral InsulinMarket Forecasts and Competitive StructureDemand AnalysisPricing AnalysisRevenue ForecastsCompetitive StructureProduct AnalysisMarket Share AnalysisU.S. Diabetes Therapies and Complications Markets, Oral Diabetes Medications MarketTotal Oral Diabetes Medications MarketIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsDemand AnalysisPricing AnalysisRevenue ForecastsCompetitive StructureMarket Share AnalysisSulfonylureas MarketMarket OverviewMarket Engineering AnalysisRevenue ForecastsBiguanides MarketMarket OverviewMarket Engineering AnalysisRevenue ForecastsAlpha-Glucosidase Inhibitors MarketMarket OverviewMarket Engineering AnalysisRevenue ForecastsGlitazones MarketMarket OverviewMarket Engineering AnalysisRevenue ForecastsMarket Share AnalysisMeglitinidesMarket OverviewMarket Engineering AnalysisRevenue ForecastsU.S. Diabetes Therapies and Complications Markets, Diabetes Complications MarketTotal Diabetes Complications MarketIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsDiabetic Nephropathy MarketMarket OverviewDemand AnalysisTechnology TrendsRevenue ForecastsDiabetic Neuropathy MarketMarket OverviewDemand AnalysisTechnology TrendsDiabetic Retinopathy MarketMarket OverviewDemand AnalysisTechnology TrendsRevenue Forecasts




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.